Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FTKRE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,893
Award facts
- Contract value 100% obligated
- $1,892.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,892.90 to DMS Pharmaceutical Group Inc. for the supply of Nucala 100 mg/mL auto-injectors. The award was issued on September 23, 2025, with an ultimate completion date of September 24, 2025, and carries no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its Park Ridge location. This delivery order falls under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes firm fixed-price orders for comprehensive pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its extensive portfolio of delivery orders covering branded and generic prescription drugs, biologics, and medical consumables. The company's contract history with the Defense Logistics Agency demonstrates consistent performance in delivering specialized pharmaceutical products, including auto-injectors, vaccines, oncology treatments, and other medical supplies to Department of Defense healthcare facilities. The Nucala auto-injector delivery represents a routine fulfillment within this established supplier relationship, addressing specific pharmaceutical supply requirements for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FTKRE?
SPE2DB25FTKRE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FTKRE worth?
The government has obligated $1,893 on SPE2DB25FTKRE.
Is contract SPE2DB25FTKRE an order under another contract?
Yes. SPE2DB25FTKRE is a delivery order under SPE2DB22D9112, an indefinite delivery contract.
Was contract SPE2DB25FTKRE competed?
The extent of competition for SPE2DB25FTKRE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award